Linkedbio is the newly launched services provided by Lingmed. We help companies to understand and monitor China market opportunities, define the right strategies and work with the right partners

  • Linkedbio Partnering:

    Lingmed analyst team evaluates the innovative biotech products, technologies and medical devices to estimate the market size, risk & opportunities, to identify the right partner for the asset. Lingmed team will arrange partnering meetings to facilitate the direct dialogues, suggest deal structure to support deal closing

  • Linkedbio Analysis:

    Lingmed analyst team conducts desk researches and interviews to get insights on China market, we provide tailored product China market sizing analysis, deal valuation and competitive landscape reports to our clients

Latest Lingmed asset recommendation
Japanese Innovative Oncology Project —— Treating Biliary Tract Cancer, Non-Small Cell Lung Cancer, and Urothelial Carcinoma Seeking partner in Greater China (LMP2828) (Tuesday, 15 Sep 2026)
  • Project ID：LMP2828
  • Project Description：Liposomal gemcitabine- DNA polymerase inhibitor
  • Indications：Biliary tract cancer (FDA Orphan Drug Designation), Phase 1；Non-small cell lung cancer and urothelial cancer, Phase 2a
  • Partnering Needs: Actively seeking strategic partners for licensing out or co-development in Greater China
  • Company Description: LMC5001789 is a comprehensive Japanese group company with a pharmaceutical division dedicated to oncology, infectious diseases, and regenerative medicine
  • Development Stage, Mode of Administration, Partnering Needs, Company Description, Project Highlights......
Related asset recommendations
European Innovative Oncology Nuclear Medicine Project ——T-cell lymphoma Therapy Monitoring & Theragnostics Seeking partner in Greater China (LMP2826)
European Innovative CNS/Pain Project ——Treating Acute/Chronic Pain Seeking partner in Greater China (LMP2825)
Latest Lingmed monthly webinar
Analysis of drug targets and key pharmaceutical companies in pain therapeutic area, are you ready? (Thursday, 14 Nov 2024)
Event details
  • Potential innovative targets for new pain drugs
  • Breakthroughs and innovations of non-addictive pain drugs
  • Competition landscape of the top 10 domestic companies in pain therapeutic area
  • An innovative biotech roadshow
Related monthly webinars
Application of nano-antibodies in autoimmune diseases, are you ready?
Breakthroughs & progress of antiepileptic drugs, are you ready?
General information
Product > 460
Company > 835
Deals > 391
Reports > 203
Non-confi PDF > 284